Founding Engineer

About Delfa Billions of people still suffer from every-day diseases.

One key reason?

Clinical trials are broken .

Despite $120 billion spent each year, most trials are delayed due to bottlenecks like patient recruitment.

Delfa is fixing this with autonomous AI agents.

We're building AI agents to automate clinical trials.

In the last year from we’ve already: Deployed onto 500 trials across multiple conditions Reached seven figures in ARR, growing 25% MoM Raised an oversubscribed $3.8m seed from …